Vicplas International Ltd
SGX:569

Watchlist Manager
Vicplas International Ltd Logo
Vicplas International Ltd
SGX:569
Watchlist
Price: 0.093 SGD
Market Cap: S$47.6m

Gross Margin

53.1%
Current
Improving
by 1.1%
vs 3-y average of 52.1%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
53.1%
=
Gross Profit
S$61.5m
/
Revenue
S$115.8m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
53.1%
=
Gross Profit
S$61.5m
/
Revenue
S$115.8m

Peer Comparison

Country Company Market Cap Gross
Margin
SG
Vicplas International Ltd
SGX:569
47.5m SGD
Loading...
US
Abbott Laboratories
NYSE:ABT
200.1B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
174.7B USD
Loading...
US
Stryker Corp
NYSE:SYK
146.9B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
126.6B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
110.4B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR
Loading...
US
Becton Dickinson and Co
NYSE:BDX
52.7B USD
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
49.9B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48B USD
Loading...
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.3B USD
Loading...

Market Distribution

Higher than 78% of companies in Singapore
Percentile
78th
Based on 977 companies
78th percentile
53.1%
Low
-1 390 526.2% — 14.7%
Typical Range
14.7% — 43.4%
High
43.4% — 515 258.2%
Distribution Statistics
Singapore
Min -1 390 526.2%
30th Percentile 14.7%
Median 28.1%
70th Percentile 43.4%
Max 515 258.2%

Vicplas International Ltd
Glance View

Market Cap
47.6m SGD
Industry
Health Care

VicPlas International Ltd. operates as an investment holding company, which engages in the research, design, development, and manufacture of medical devices and plastic building products. The firm designs, develops and manufactures sterile and non-sterile medical devices through its subsidiaries, Forefront Medical Technology (Pte) Ltd, Forefront Medical Investment Pte. Ltd. and XentiQ (Pte.) Ltd. in Singapore; Forefront (Xiamen) Medical Devices Co., Ltd and Forefront Medical Technology (Jiangsu) Co., Ltd in China; and Arrow Medical Limited in the United Kingdom. The firm manufactures and distributes piping systems for diverse industries, including waste and potable water systems for residential homes, schools, commercial and industrial buildings; underground electrical and internal building wire piping systems; and data and signal line piping systems by telecommunications companies, through its subsidiaries, Vicplas Holdings Pte Ltd in Singapore and Rimplas Industries Sdn. Bhd. in Malaysia.

Intrinsic Value
0.159 SGD
Undervaluation 41%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
53.1%
=
Gross Profit
S$61.5m
/
Revenue
S$115.8m
What is Vicplas International Ltd's current Gross Margin?

The current Gross Margin for Vicplas International Ltd is 53.1%, which is above its 3-year median of 52.1%.

How has Gross Margin changed over time?

Over the last 3 years, Vicplas International Ltd’s Gross Margin has increased from 52.6% to 53.1%. During this period, it reached a low of 51.5% on Jan 31, 2024 and a high of 53.1% on Aug 1, 2025.

Back to Top